GSS Genetic Signatures Limited
—Mkt Cap: —P/E: —1d ago
Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas. The company offers enteric bacteria, Enteroaggregative E.coli aggR an…
Industry Peers
Biotechnology$128.87BUSDP/E 29.6
$94.42BUSD
$81.99BUSDP/E 19.1
$53.47BUSDP/E 32.5
$53.22BUSDP/E 31.6
$44.02BUSDP/E 17.8
$42.56BUSDP/E 66.4
$40.57BUSD
$34.45BUSDP/E 30.4
$31.32BUSDP/E 39.3
$24.59BUSD
$23.32BUSDP/E 31.7
$23.26BUSDP/E 29.8
$22.96BUSDP/E 14.0
$22.66BUSD
$21.67BUSD
$15.57BUSDP/E 19.3
$14.91BUSDP/E 17.4
$13.92BUSDP/E 14.7
$13.79BUSDP/E 33.4
Key Statistics
Company
Market Cap—
Enterprise Value-2.50M USD
Revenue (TTM)13.36M USD
Gross Profit3.45M USD
Net Income (TTM)-9.68M USD
Revenue/Share0.09 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU000000GSS4
Valuation
P/E (Trailing)—
P/E (Forward)-1.78
PEG—
EV/EBITDA0.32
EV/Revenue-0.19
P/S0.94
P/B0.51
EPS (TTM)-0.06
EPS (Forward)-0.04
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin34.52%
Oper. Margin-56.40%
EBITDA Margin-58.27%
Profit Margin-96.91%
ROE-39.21%
ROA-36.42%
Growth
Revenue Growth-5.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.37M USD
CapEx (TTM)724.26K USD
FCF Margin-26.38%
FCF Yield—
Net Debt-15.06M USD
Net Debt/EBITDA1.93
Balance Sheet
Debt/Equity0.01
Current Ratio13.10
Quick Ratio10.80
Book Value/Sh0.16 AUD
Cash/Share0.10 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.3100 AUD
Target Range0.3100 AUD – 0.3100 AUD
# Analysts1
Ownership
Shares Out.227.14M
Float138.63M
Insiders28.24%
Institutions40.80%
Technical
SMA 500.0757 AUD
SMA 2000.0960 AUD
Beta0.63
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)1.16M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—